drugset / Trial / NCT00662610

A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure

NCT00662610

Phase 1 Completed 120 enrolled NicOx
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the effect of naproxcinod vs. naproxen on arterial blood pressure patients with osteoarthritis and controlled essential hypertension

Timeline

Start
2008-03
Primary completion
2008-08
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule 750 mg
Subject naproxcinod Other / unclassified 1125 mg